Morgan Stanley Acasti Pharma Inc. Transaction History

Morgan Stanley

  • $1.35 Trillion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.62 - $3.66 $4,568 - $26,970
-7,369 Reduced 39.48%
11,295 $6,000
Q2 2022

Oct 27, 2022
SELL
$0.85 - $1.29 $30,430 - $46,182
-35,800 Reduced 65.73%
18,664 $16,000
Q2 2022

Aug 15, 2022
SELL
$0.85 - $1.29 $30,430 - $46,182
-35,800 Reduced 65.73%
18,664 $16,000
Q1 2022

Oct 27, 2022
BUY
$0.94 - $1.43 $33,652 - $51,194
35,800 Added 191.81%
54,464 $66,000
Q1 2022

May 13, 2022
BUY
$0.94 - $1.43 $19,865 - $30,220
21,133 Added 63.4%
54,464 $66,000
Q4 2021

Feb 14, 2022
BUY
$1.07 - $2.01 $19,882 - $37,349
18,582 Added 125.99%
33,331 $42,000
Q3 2021

Nov 15, 2021
BUY
$1.96 - $4.72 $28,908 - $69,615
14,749 New
14,749 $29,000

About Acasti Pharma Inc.

ACST Quotes by TradingView
  • Ticker ACST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,610,100
  • Market Cap $146M
  • Description
  • Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
More about ACST
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email